Skip to main content

Table 2 Single nucleotide polymorphisms employed in first stage

From: Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration

Marker[48] Chromosome Base-pair[49]
(Build 36.3)
Base-pair[49]
(Build 37.1)
Gene
rs1061170 1 194,925,860 196,659,237 CFH (exon 9)
rs2274700 1 194,949,570 196,682,947 CFH (exon 10)
rs403846 1 194,963,360 196,696,737 CFH (intron 14)
rs12144939 1 194,965,568 196,698,945 CFH (intron 15)
rs1409153 1 195,146,628 196,880,005 CFHR4
rs1750311 1 195,220,848 196,954,225 CFHR5
rs10922153 1 195,245,238 196,978,615 CFHR5
rs698859 1 195,274,988 197,008,365 F13B
rs2990510 1 195,287,281 197,020,658 F13B
rs9332739 6 32,011,783 31,903,804 C2
rs641153 6 32,022,159 31,914,180 CFB
rs10490924 10 124,204,438 124,214,448 LOC387155/ARMS2
rs2230199 19 6,669,387 6,718,387 C3